Response to Gultekin et al. regarding SECRAB trial toxicity.

Response to Gultekin et al. regarding SECRAB trial toxicity. Radiother Oncol. 2020 Feb 08;: Authors: Fernando IN, Lax S, Ahmed I PMID: 32046873 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32046873?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - February 7, 2020 Category: Radiology Authors: Fernando IN, Lax S, Ahmed I Tags: Radiother Oncol Source Type: research

More News: Cancer & Oncology | Radiology | Toxicology